論文 - 斉藤 まなぶ
-
Thioridazine inhibits risperidone metabolism - A clinically relevant drug interaction
T Nakagami, N Yasui-Furukori, M Saito, K Mihara, R De Vries, T Kondo, S Kaneko
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY 25 ( 1 ) 89 - 91 2005年02月
-
Steady-state pharmacokinetics of a new antipsychotic agent perospirone and its active metabolite, and its relationship with prolactin response.(共著)
Yasui-Furukori N, Furukori H, Nakagami T, Saito M, Inoue Y, Kaneko S, Tateishi T.
Therapeutic Drug Monitoring 26 ( 4 ) 361 - 365 2004年08月
-
Steady-state pharmacokinetics of a new antipsychotic agent perospirone and its active metabolite, and its relationship with prolactin response
N Yasui-Furukori, H Furukori, T Nakagami, M Saito, Y Inoue, S Kaneko, T Tateishi
THERAPEUTIC DRUG MONITORING 26 ( 4 ) 361 - 365 2004年08月
-
Establishment of new cloned enzyme donor immunoassays (CEDIA) for haloperidol and bromperidol.(共著)
Yasui-Furukori N, Saito M, Furukori H, Inoue Y, Someya T, Kaneko S, Tateishi T.
Therapeutic Drug Monitoring 26 ( 3 ) 336 - 341 2004年06月
-
Establishment of new cloned enzyme donor immunoassays (CEDIA((R))) for haloperidol and bromperidol
N Yasui-Furukori, M Saito, H Furukori, Y Inoue, T Someya, S Kaneko, T Tateishi
THERAPEUTIC DRUG MONITORING 26 ( 3 ) 336 - 341 2004年06月
-
Poor reliability of therapeutic drug monitoring data for haloperidol and bromperidol using enzyme immunoassay.(共著)
Yasui-Furukori N, Furukori H, Saito M, Inoue Y, Kaneko S, Tateishi T.
Therapeutic Drug Monitoring 25 ( 6 ) 709 - 714 2003年12月
-
Poor reliability of therapeutic drug monitoring data for haloperidol and bromperidol using enzyme immunoassay
N Yasui-Furukori, H Furukori, M Saito, Y Inoue, S Kaneko, T Tateishi
THERAPEUTIC DRUG MONITORING 25 ( 6 ) 709 - 714 2003年12月